These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 24719485)
1. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease. Hong JY; Oh JS; Lee I; Sunwoo MK; Ham JH; Lee JE; Sohn YH; Kim JS; Lee PH Neurology; 2014 May; 82(18):1597-604. PubMed ID: 24719485 [TBL] [Abstract][Full Text] [Related]
2. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease. Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830 [TBL] [Abstract][Full Text] [Related]
3. Levodopa-Induced Dyskinesia in Parkinson Disease Specifically Associates With Dopaminergic Depletion in Sensorimotor-Related Functional Subregions of the Striatum. Labrador-Espinosa MA; Grothe MJ; Macías-García D; Jesús S; Adarmes-Gómez A; Muñoz-Delgado L; Fernández-Rodríguez P; Martín-Rodríguez JF; Huertas I; García-Solís D; Mir P Clin Nucl Med; 2021 Jun; 46(6):e296-e306. PubMed ID: 33782308 [TBL] [Abstract][Full Text] [Related]
4. The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease. Chung SJ; Yoo HS; Lee HS; Oh JS; Kim JS; Sohn YH; Lee PH Clin Nucl Med; 2018 Nov; 43(11):787-792. PubMed ID: 30153150 [TBL] [Abstract][Full Text] [Related]
5. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients. Rossi C; Genovesi D; Marzullo P; Giorgetti A; Filidei E; Corsini GU; Bonuccelli U; Ceravolo R Clin Neuropharmacol; 2017; 40(1):34-36. PubMed ID: 27941527 [TBL] [Abstract][Full Text] [Related]
6. Patterns of striatal dopamine depletion in early Parkinson disease: Prognostic relevance. Chung SJ; Lee HS; Yoo HS; Lee YH; Lee PH; Sohn YH Neurology; 2020 Jul; 95(3):e280-e290. PubMed ID: 32616674 [TBL] [Abstract][Full Text] [Related]
7. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease? Chung SJ; Yoo HS; Lee HS; Jeong HE; Kim SJ; Oh JS; Kim JS; Sohn YH; Lee PH CNS Drugs; 2018 Oct; 32(10):971-979. PubMed ID: 30027399 [TBL] [Abstract][Full Text] [Related]
8. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions. Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448 [TBL] [Abstract][Full Text] [Related]
9. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease. Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292 [TBL] [Abstract][Full Text] [Related]
10. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease. Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471 [TBL] [Abstract][Full Text] [Related]
11. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779 [TBL] [Abstract][Full Text] [Related]
12. Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off. Chung SJ; Lee Y; Oh JS; Kim JS; Lee PH; Sohn YH Parkinsonism Relat Disord; 2018 Aug; 53():96-100. PubMed ID: 29776864 [TBL] [Abstract][Full Text] [Related]
13. Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson's disease. Yoo HS; Lee EC; Chung SJ; Ye BS; Sohn YH; Seong JK; Lee PH Sci Rep; 2022 Jul; 12(1):12631. PubMed ID: 35879381 [TBL] [Abstract][Full Text] [Related]
14. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease. Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657 [TBL] [Abstract][Full Text] [Related]
15. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Payer DE; Guttman M; Kish SJ; Tong J; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I Neurology; 2016 Jan; 86(3):224-30. PubMed ID: 26718579 [TBL] [Abstract][Full Text] [Related]
16. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism. Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520 [TBL] [Abstract][Full Text] [Related]
17. Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia. Kipfer S; Stephan MA; Schüpbach WM; Ballinari P; Kaelin-Lang A Arch Neurol; 2011 Aug; 68(8):1037-9. PubMed ID: 21825240 [TBL] [Abstract][Full Text] [Related]
18. Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD. Yoo HS; Chung SJ; Lee YH; Lee HS; Ye BS; Sohn YH; Lee PH Neurology; 2019 Mar; 92(13):e1468-e1478. PubMed ID: 30796137 [TBL] [Abstract][Full Text] [Related]
19. Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia? Chung SJ; Yoo HS; Lee HS; Lee PH; Sohn YH J Parkinsons Dis; 2019; 9(1):241-247. PubMed ID: 30741690 [TBL] [Abstract][Full Text] [Related]
20. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia. Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]